Advertisement · 728 × 90

Posts by National Centre for Antimicrobial Stewardship

Our modus operandi for our programs - the Learning Health System.

5 months ago 1 0 0 0
Preview
Applying the Learning Health System framework to overcome barriers in antimicrobial decision support: lessons from the Guidance redesign | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core Applying the Learning Health System framework to overcome barriers in antimicrobial decision support: lessons from the Guidance redesign - Volume 5 Issue 1

Read on in this letter to the editor--Applying the Learning Health System framework to overcome barriers in antimicrobial decision support: lessons from the Guidance redesign doi.org/10.1017/ash....

5 months ago 4 1 0 2
Post image

Fever's going up up up... 🎶
Remember to take cultures before starting antibiotics.

Stay tuned for more NCAS Halloween posters over the coming weeks.

@NCASHalloween2025 #antimicrobialoween

6 months ago 2 2 1 0
Preview
An interesting shift in the expected skills profile. While AI and… | Flt.Lt. Sridhar Chakravarthi Mulakaluri© | 101 comments An interesting shift in the expected skills profile. While AI and analytical skills becoming core skills is an obvious one, the more interesting quadrants are emerging skills and Out-of-focus skills. ...

www.linkedin.com/posts/fltltm...

1 year ago 3 0 0 0
Post image

New Frontiers in Antimicrobial Stewardship @escmid.bsky.social

Keynote lecture: Karin Thursky @ncas.bsky.social

How can we reframe + conceptualize #AMS to work for 2025 + beyond.

Who outside of healthcare really know the ins and outs of what #AMR #AMS mean?

#ESCMIDGlobal #ESCMID2025

1 year ago 9 1 0 0
Post image

Appreciate the shoutout by Prof Thursky on the key role played by #pharmacists in #antimicrobialstewardship and the importance of prescriber providing indication to facilitate appropriateness assessment.
@ncas.bsky.social
#ESCMIDGlobal

1 year ago 16 2 1 0
Post image

#AI is here + will become key in #antimicrobialstewardship #AMS

Flagged by Prof Thursky @ncas.bsky.social at #ESCMID2025 #ESCMIDGlobal - this paper is a great blueprint for implementing AI in AMS programmes

Link: www.thelancet.com/journals/lan...

1 year ago 9 5 0 1
Post image

Glad to hear how #Epic EMR data are being handled to support #antimicrobialstewardship
@ncas.bsky.social #ESCMIDGlobal

1 year ago 5 1 0 0
Post image

Importance of combining appropriateness and consumption to form a more complete picture of antimicrobial use at a local hospital and national level.

@cazchen.bsky.social presenting a comparative analysis of 192 hospitals across two national programs.

@ausantibiotics.bsky.social #ASA2025

1 year ago 10 3 0 0
Post image

Two sides to every coin. Free range chooks - great for animal welfare, perhaps not so much for #AMS.

Allegra Schermuly presenting findings from focus groups on consumer attitudes to antibiotic use #ASA2025

1 year ago 7 2 0 0
Advertisement
Post image Post image

What a way to wrap up Day 1 of #ASA2025 with our Director Prof Kas Thursky delivering the prestigious Howard Florey Oration. We’re so proud to be a part of her visionary work pioneering #AMS in Australia and internationally and driving the field forward.

@ausantibiotics.bsky.social

1 year ago 14 5 1 1

@cazchen.bsky.social @lisadrepi.bsky.social @josephinew.bsky.social

1 year ago 0 0 0 0
Post image

Proud of our team of clinician researchers at the (unofficial) NCAS session at #ASA2025

1 year ago 8 3 1 0
Post image Post image

A huge amount of careful thought, validation work and technical gymnastics that went into the development of real time AMS reports for AMS teams.

Ms Jenna Maleki presenting on the development of dashboard reports in the Guidance application.

@ausantibiotics.bsky.social #ASA2025

1 year ago 5 2 0 0
Post image Post image

Pharmacist Josephine Wen discussing the value of concise targeted auditing tools in conjunction with larger point prevalence audits for AMS programs.

@ausantibiotics.bsky.social #ASA2025

1 year ago 6 3 0 0
Post image Post image

A national audit of 200 hospitals showed ongoing poor prescribing in surgical prophylaxis, in particular with extended durations of post-operative prophylaxis.
Dr Courtney Ierano presenting the 2023 results of our Surgical NAPS program @ausantibiotics.bsky.social

#AMSsky #ASA2025

1 year ago 5 3 0 0

Excited to showcase the work of our team at the @ausantibiotics.bsky.social conference

#ASA2025

1 year ago 4 2 0 0
Preview
Fluoroquinolone consumption and resistance after an Antibiotic Stewardship Team intervention—an interventional study in a single hospital in southern Poland from 2018–2023. Among the many classes of antibiotics, fluoroquinolones (FQ) are widely used in empiric treatment. Unfortunately, resistance to FQ is progressively ri…

We shouod not forget about the effectiveness of foundational AMS activities. Restriction and pre approval can be very effective (especially if combined with post prescription review) www.sciencedirect.com/science/arti...

1 year ago 0 0 0 0

Please read this thread and support the prioritisation of #AMR/#AMS grand funding.

1 year ago 1 0 0 0

Exciting News! 🌟

Come and join us in lovely Vienna for the 3rd Behavioral Insights & Antimicrobial Resistance Workshop

📅 15–16 May 2025 📍University of Vienna (and online)

👉 Register by March 31st: www.a-bc.network/active.html

1 year ago 3 1 0 0
Advertisement

A starter pack for people interested in behavioral, cognitive and cultural aspects of antimicrobial resistance.

Happy to add you if you are active in this area.
go.bsky.app/9i8zPz

See also www.a-bc.network

#AMR #AntibioticResistance #AntibioticStewardship #BehavioralInsights #AMRBehaviorChange

1 year ago 19 11 6 0

Great thread about the real world experience of procalcitonin to guide IV antis in children. Low compliance with the algorithm, with a test that also disrupted routine workflow. Diagnostic stewardship requires careful implementation design.

1 year ago 5 2 0 0
Kaplan–Meier curves showing device failure through 8 weeks after insertion.

Kaplan–Meier curves showing device failure through 8 weeks after insertion.

Chlorhexidine or hydrophobic PICCs were not superior to standard polyurethane PICCs for the prevention of device failure due to infectious or noninfectious complications. Read the full PICNIC trial results: nej.md/3Pqk25M

#MedSky

1 year ago 29 3 0 4
A poster of cartoon medication pills dressed up as different christmas cartoon characters. There are 16 characters - from right to left, top to bottom there is 1) a pill in a christmas stocking 2) a pill wrapped as a present with a bow, 3) a pill as a christmas pudding 4) a pill as a christmas angel 5) a pill as a snow globe 6) a pill as a gingerbread person 7) a pill as Mrs Claus 8) a pill as a christmas tree 9) a pill as a reindeer 10) a pill as Santa Claus 11) a pill as a christmas elf 12) a pill striped like a candy cane 13) a pill with a Grinch face 14) a pill as a snowman 15) a pill as a christmas bell and 16) a pill as a christmas light globe

A poster of cartoon medication pills dressed up as different christmas cartoon characters. There are 16 characters - from right to left, top to bottom there is 1) a pill in a christmas stocking 2) a pill wrapped as a present with a bow, 3) a pill as a christmas pudding 4) a pill as a christmas angel 5) a pill as a snow globe 6) a pill as a gingerbread person 7) a pill as Mrs Claus 8) a pill as a christmas tree 9) a pill as a reindeer 10) a pill as Santa Claus 11) a pill as a christmas elf 12) a pill striped like a candy cane 13) a pill with a Grinch face 14) a pill as a snowman 15) a pill as a christmas bell and 16) a pill as a christmas light globe

Love this jolly #AntimicrobialStewardship holiday poster from @ncas.bsky.social

#AMS #AMR

1 year ago 12 3 0 0
Post image

I don't want a lot for Christmas... 🎵

www.ncas-australia.org/ClinicalFact...

#antimicrobialmas #AMSsky

1 year ago 2 3 0 0
Preview
Doubts over landmark heart drug trial: ticagrelor PLATO study A top selling antiplatelet drug has never quite shaken off doubts about its advantage over cheaper rivals. With generic versions of ticagrelor about to launch, Peter Doshi takes a fresh look at the ev...

www.bmj.com/content/387/...

Have not heard about this before, but very interesting read. Maybe it’s time that drug companies lose any control over clinical trials to obtain approval.

1 year ago 9 1 1 1

#IDsky

1 year ago 2 0 0 0
Advertisement